Scancell Holdings Share News (SCLP)
SCLP Share
SCLP Share
SCLP Share
SCLP Share
SCLP
SCLP Share
SCLP Level 2
SCLP Live
SCLP Broker
SCLP Directors
SCLP Financial
SCLP
SCLP Short
SCLP
Last checked at -
LONDON (Alliance News) - Scancell Holdings PLC said Friday its DNA Immunobody technology platform had been granted a patent by the US Patent and Trademark Office. Scancell said the patent was key for the protection of its pipeline of vaccines utilising the technology. It has already been gr
6 Jun 14 08:52Scancell's shares advanced after announcing "encouraging results" from the clinical trial of its SCIB1 ImmunoBody drug for the treatment of stage III/IV melanoma. The phase 1 and 2 trial tested the safety and tolerability of four dose levels of SCIB1 administered intramuscularly using an electropo
2 Jun 14 11:08LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Monday.<br />-------<br />FTSE 100 - WINNERS<br />-------<br /><strong>Anglo American</strong>, up 1.9%, <strong>Rio Tinto</strong>, up 1.7%, <strong>Glencore</strong>, up 1.4
2 Jun 14 10:39LONDON (Alliance News) - Cancer treatment developer Scancell Holdings PLC saw its shares rise Monday after it said the latest results from a trial of its SCIB1 ImmunoBodyÒ treatment on skin cancer had shown further evidence of tumour reduction and disease control, enhanced immune responses and "h
2 Jun 14 08:04LONDON (Alliance News) - Oxford Technology VCT PLC saw its net asset value per share decline in the year to end-February, and said it was appealing the withdrawal of its venture capital trust status. The trust posted a net asset value per share of 65 pence per share, down from 74 pence in t
27 May 14 12:47LONDON (Alliance News) - Scancell Holdings PLC said Thursday that it will announce the latest data from its ongoing Phase I/II clinical trial of its SCIB1 ImmunoBody treatment for stage III/IV melanoma will be presented at the American Society of Clinical Oncology meeting in Chicago at the end of
15 May 14 12:46LONDON (Alliance News) - <strong>Lloyds Banking Group</strong> kicked off the first-quarter bank earnings season Thursday, reporting that its pretax profit dropped by a third to GBP1.37 billion after last year was buoyed by gains on the sale of government securities.<br /><br />However, its un
1 May 14 13:03LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday.<br />-------<br /><strong>FTSE 100 - WINNERS</strong><br />-------<br /><strong>Lloyds Banking</strong> Group, up 4.8%. The banking group is the biggest riser in the
1 May 14 11:27LONDON (Alliance News) - Cancer treatment developer Scancell Holdings PLC saw its shares rise Thursday after it appointed long-time consultant Dr Sally Adams to its board as development director with immediate effect. In a statement, the company, which is developing immunotherapies to treat
1 May 14 10:29LONDON (Alliance News) - Scancell Holdings PLC Friday said that it will announce the results of phase one and two of its clinical trial in patients with stage three and four melanoma at the American Association for Cancer Research annual meeting in San Diego next Tuesday. Scancell Holdings
4 Apr 14 09:55LONDON (Alliance News) - Scancell Holdings PLC Friday said it has completed patient dosing with 8mg of SCIB1 ImmunoBody in part one of its on-going phase 1/2 clinical trial in patients with Stage III/IV melanoma. The trial followed a study the firm conducted which showed that a 4mg dose of
21 Mar 14 09:11LONDON (Alliance News) - Scancell Holdings PLC Tuesday said its patent application for Moditope has been published, with a view to guarding the platform until 2033 once the patent is granted. In a statement, Scancell said the application for the Modicope platform describes how it uses certa
18 Feb 14 09:19LONDON (Alliance News) - Scancell Holdings PLC said Tuesday its SCIB1 ImmunoBody metastatic melanoma treatment had been granted orphan drug designation by the US Food and Drug Administration. This designation means that Scancell can qualify for a 50% tax credit for clinical trials of the tr
11 Feb 14 09:50<span style="color: #333333; font-family: HelveticaNeue, 'Helvetica Neue', HelveticaNeueRoman, HelveticaNeue-Roman, 'Helvetica Neue Roman', TeXGyreHerosRegular, Helvetica, Tahoma, Geneva, Arial, sans-serif; font-size: 13px; font-style: normal; font-variant: normal; font-weight: 300; letter-spa
11 Feb 14 09:36LONDON (Alliance News) - UK shares have opened higher Tuesday ahead of the testimony later in the day by new US Federal Reserve Chair Janet Yellen. <br /><br /><strong>Barclays</strong> has said it is in a position to increase its leverage ratio target, despite a loss in its final quarter. Bar
11 Feb 14 08:32
Last checked at